European life sciences venture capital firm HealthCap appointed Dr. Mårten Steen as co-managing partner, taking a seat alongside Founding Partner Björn Odlander.
Mårten became a partner at the Stockholm, Sweden-based HealthCap in 2010 and has played key roles in many of the firm´s most successful investments, including Wilson Therapeutics, a developer of treatments for ultra-rare orphan diseases that was sold in 2020 for about $800 million.
HealthCap also announced a new hire and several other promotions.
- Kristina Ekberg joined HealthCap as partner and . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.